|
Diphenoxylate and Atropine Liquid
|
|
Lomanate Liquid; Lomotil Liquid
|
Diphenoxylate and Atropine Liquid Clinical Trials
- Trial Comparing Atropine to Atropine Plus a Plano Lens for the Sound Eye for Amblyopia in Children 3 to <7 Years Old
ClinicalTrials.gov Identifier: NCT00315302 - Active, not recruiting
Amblyopia
- Trial Comparing Daily Atropine versus Weekend Atropine
ClinicalTrials.gov Identifier: NCT00094614 - Completed
Amblyopia
- Analysis of Atropine and Propranolol Induced Changes
ClinicalTrials.gov Identifier: NCT00251602 - Active, not recruiting
Healthy
- Trial Comparing Patching Versus Atropine for Amblyopia in 7 to < 13 Year Olds
ClinicalTrials.gov Identifier: NCT00315328 - Active, not recruiting
Amblyopia
- Amblyopia Treatment Study (ATS)
ClinicalTrials.gov Identifier: NCT00000170 - Active, not recruiting
Amblyopia
- An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children with HIV Infection: Canada
ClinicalTrials.gov Identifier: NCT00162188 - Recruiting
HIV Infection
- Measurement of Stress During Anesthesia With ”Pain Detector” on Patients Receiving Atropine
ClinicalTrials.gov Identifier: NCT00328900 - Recruiting
Hemorrhoids; Fissure in Ano
- Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy
ClinicalTrials.gov Identifier: NCT00575523 - Recruiting
Arrhythmia; Respiratory Arrest
- Study of Myopia Prevention in Children With Low Concentration of Atropine
ClinicalTrials.gov Identifier: NCT00541177 - Recruiting
Myopia
- Study of Topiramate Administered as Liquid or Sprinkles in Infants (Aged 1-23 Months) With Refractory POS
ClinicalTrials.gov Identifier: NCT00233012 - Active, not recruiting
Seizures
- Study of Three Capsaicin Dermal Liquid Formulations on Epidermal Nerve Fiber Immunostaining and Sensory Function
ClinicalTrials.gov Identifier: NCT00528216 - Active, not recruiting
Pain
- Safety and Efficacy Study of 0.5%, 0.1% & 0.01% Atropine Treatment to Both Eyes In Treatment of Myopia In Children
ClinicalTrials.gov Identifier: NCT00371124 - Recruiting
Myopia
- Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of MEDI-493, Synagis
ClinicalTrials.gov Identifier: NCT00233064 - Active, not recruiting
Chronic Lung Disease
- Daily Patching Plus Daily Atropine for Residual Amblyopia in Children 3 to <8 Years Old
ClinicalTrials.gov Identifier: NCT00506675 - Recruiting
Amblyopia
- A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals’ HRV Liquid Vaccine in Healthy Infants.
ClinicalTrials.gov Identifier: NCT00432380 - Active, not recruiting
Rotavirus Gastroenteritis
- Liquid Meal Replacements in Conjunction With Lifestyle Intervention in Overweight Adolescents
ClinicalTrials.gov Identifier: NCT00207519 - Active, not recruiting
Overweight; Obesity
- A Study in Infants to Test Two Preparations (Freeze-Dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
ClinicalTrials.gov Identifier: NCT00382772 - Active, not recruiting
Gastroenteritis
- Efficacy and Safety Study of Oral Glycopyrrolate Liquid to Manage Problem Drooling Associated With Cerebral Palsy or Other Neurologic Conditions in Children
ClinicalTrials.gov Identifier: NCT00425087 - Active, not recruiting
Sialorrhea; Cerebral Palsy; Neurological Condition; Mental Retardation
- A Study of the Safety and Effectiveness of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00175877 - Active, not recruiting
Rheumatoid Arthritis
- Evaluation of Liquid vs. Tablet Buprenorphine - 6
ClinicalTrials.gov Identifier: NCT00000341 - Active, not recruiting
Opioid-Related Disorders
- Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
ClinicalTrials.gov Identifier: NCT00312091 - Recruiting
HIV Infections
- High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease
ClinicalTrials.gov Identifier: NCT00247143 - Recruiting
HIV; AIDS
- A Study of the Safety of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients with Active Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00160641 - Active, not recruiting
Rheumatoid Arthritis
- Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients with Chronic Hepatitis B
ClinicalTrials.gov Identifier: NCT00071201 - Active, not recruiting
Chronic Hepatitis B
- Bio-Availability of a New Liquid Tumeric Extract
ClinicalTrials.gov Identifier: NCT00542711 - Not yet recruiting
Healthy
- Six Months, Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation in Adolescents (>12 Years) and Adults With Moderate to Severe Persistent Allergic Asthma
ClinicalTrials.gov Identifier: NCT00500539 - Recruiting
Asthma
- An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children with HIV Infection
ClinicalTrials.gov Identifier: NCT00162227 - Recruiting
HIV Infection
- Safety Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Condition
ClinicalTrials.gov Identifier: NCT00491894 - Recruiting
Sialorrhea; Cerebral Palsy; Neurological Conditions; Mental Retardation
- A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules
ClinicalTrials.gov Identifier: NCT00281606 - Not yet recruiting
HIV Infection
- Myopia Control by Combining Auricular Acupoint and Atropine Eyedrops
ClinicalTrials.gov Identifier: NCT00457717 - Completed
Myopia
- An Evaluation of Treatment of Amblyopia in Children 7 To <18 Years Old
ClinicalTrials.gov Identifier: NCT00094692 - Completed
Amblyopia
- Enbrel Liquid Immunogenicity Protocol
ClinicalTrials.gov Identifier: NCT00249041 - Completed
Rheumatoid Arthritis
- Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)
ClinicalTrials.gov Identifier: NCT00192387 - Completed
Influenza
- Randomized Study of Two Interventions for Liquid Aspiration: Short-Term and Long-Term Effects
ClinicalTrials.gov Identifier: NCT00000362 - Terminated
Pneumonia, Aspiration
- To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)
ClinicalTrials.gov Identifier: NCT00345956 - Completed
Gastroenteritis; Rotavirus Infections
- Trial to Assess the Safety and Tolerability of the Liquid Formulation of CAIV-T in Healthy Children.
ClinicalTrials.gov Identifier: NCT00192400 - Completed
Healthy
- Assessing Mucociliary Clearance and Airway Liquid Volume in the CF Airway
ClinicalTrials.gov Identifier: NCT00248755 - Completed
Cystic Fibrosis
- Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)
ClinicalTrials.gov Identifier: NCT00192231 - Completed
Influenza
- Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children
ClinicalTrials.gov Identifier: NCT00192322 - Completed
Influenza
- Trial to Compare the Safety, Tolerability, Immunogenicity and Efficacy of Three Dose Levels of a Liquid Formulation of Influenza Virus Vaccine, (CAIV-T) in Healthy Children
ClinicalTrials.gov Identifier: NCT00192374 - Completed
Healthy
- A Phase II Randomized, Double-Blind, Two-Period Cross-Over Study to Evaluate the Pharmacokinetics, Safety and Tolerability of a Liquid Formulation of Palizvizumab (MEDI-493, Synagis)
ClinicalTrials.gov Identifier: NCT00240929 - Completed
-Unhealthy Children With a History of Prematurity
- Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults
ClinicalTrials.gov Identifier: NCT00192192 - Completed
Influenza
- Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy Subjects
ClinicalTrials.gov Identifier: NCT00413426 - Completed
Healthy
- A Randomized, Double-Blind Trial To Assess The Safety And Relative Efficacy Of CAIV-T Against Inactivated Influenza Vaccine In Children 6-59 Months Of Age
ClinicalTrials.gov Identifier: NCT00128167 - Completed
Influenza
- Biomarkers of Homeopathy in Fibromyalgia
ClinicalTrials.gov Identifier: NCT00065702 - Completed
Fibromyalgia
- Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
ClinicalTrials.gov Identifier: NCT00000302 - Completed
Heroin Dependence
- Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 –
ClinicalTrials.gov Identifier: NCT00192166 - Completed
Influenza
- Treatment for Subjects with Active Rheumatoid Arthritis (RA)
ClinicalTrials.gov Identifier: NCT00110903 - Completed
Rheumatoid Arthritis
- Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
ClinicalTrials.gov Identifier: NCT00567385 - Completed
Growth Hormone Deficiency (GHD)
- Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine(CAIV-T)in Healthy Adults Aged 18 to 59 and Healthy Adults Aged 60 Years and Older
ClinicalTrials.gov Identifier: NCT00192153 - Completed
Influenza
- A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients with Active Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00160602 - Completed
Rheumatoid Arthritis
- Determinants in Antidepressant Outcomes
ClinicalTrials.gov Identifier: NCT00108316 - Terminated
Depression
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
